Device Cardiovascular

Epi-Ease Epicardial Access System

Payments companies reported to CMS as associated with Epi-Ease Epicardial Access System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$15Kassociated payments (2023-2025)
249clinicians with associated payments
1company reporting

By year

2025 $15K

Payments reported as associated with Epi-Ease Epicardial Access System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $4,925
Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,712
Cardiovascular Disease $1,498
Family $1,419
Physician Assistant $885
Interventional Cardiology $852

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Epi-Ease Epicardial Access System

These are the largest totals companies reported as associated with Epi-Ease Epicardial Access System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Nicholas Tan Rochester, MN Clinical Cardiac Electrophysiology $723.56
Carla Zacher Lexington, KY Family $274.47
Narenda Kanuru Marietta, GA Clinical Cardiac Electrophysiology $222.71
Joshua Payne Charleston, SC Clinical Cardiac Electrophysiology $199.57
Henry Huang Geneva, IL Clinical Cardiac Electrophysiology $199.57
Melissa Robinson Missoula, MT Clinical Cardiac Electrophysiology $199.57
Jackson Liang Ann Arbor, MI Clinical Cardiac Electrophysiology $199.57
Jonathan Nitz Peoria, IL Surgery $184.27
Abdi Rasekh Houston, TX Clinical Cardiac Electrophysiology $171.32
Theodore Wright Lexington, KY Thoracic Surgery (Cardiothoracic Vascular Surgery) $166.18

Prescribed Epi-Ease Epicardial Access System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.